Cargando…
PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis
BACKGROUND: Daily experience tells us that breast cancer can be controlled using standard protocols up to the advent of a relapse. Now new frontiers in precision medicine like liquid biopsy of cell free DNA (cfDNA) give us the possibility to understand cancer evolution and pick up the key mutation o...
Autores principales: | Palmieri, Maria, Baldassarri, Margherita, Fava, Francesca, Fabbiani, Alessandra, Campennì, Giuseppe Maria, Mencarelli, Maria Antonietta, Tita, Rossella, Marsili, Stefania, Renieri, Alessandra, Frullanti, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819469/ https://www.ncbi.nlm.nih.gov/pubmed/31673247 http://dx.doi.org/10.1186/s12935-019-0991-y |
Ejemplares similares
-
Two‐point‐NGS analysis of cancer genes in cell‐free DNA of metastatic cancer patients
por: Palmieri, Maria, et al.
Publicado: (2020) -
RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report
por: Gelli, Elisa, et al.
Publicado: (2020) -
Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors
por: Serio, Viola Bianca, et al.
Publicado: (2023) -
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells
por: Daga, Sergio, et al.
Publicado: (2019) -
New Candidates for Autism/Intellectual Disability Identified by Whole-Exome Sequencing
por: Bruno, Lucia Pia, et al.
Publicado: (2021)